You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -5.0 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | 3.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -37.7% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-04-30 | n/a | -2.83 | -1.06p | -25.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-04-30 | n/a | -3.03 | -1.14p | -14.1 | 0.0 | n/a | n/a | 0.0% |
| 2017-04-30 | n/a | -4.50 | -1.36p | -9.0 | 0.0 | n/a | n/a | 0.0% |
| 2018-04-30 | n/a | -4.94 | -1.34p | -9.1 | 0.0 | n/a | n/a | 0.0% |
| 2019-04-30 | n/a | -6.71 | -1.45p | -3.6 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-04-30 | 0.00 | -7.44 | -1.37p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-04-30 | 0.00 | -7.42 | -1.32p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Scancell signs collaboration agreement with antibody technology company Sharecast News | 04 Sep |
|---|---|
| Scancell losses deepen as it presses on with development Sharecast News | 20 Aug |
| Scancell to begin SCIB1 UK trial as FDA issues linger in US Sharecast News | 19 Aug |
| Result of AGM | 12-Sep-19 15:57 |
|---|---|
| First Collaboration Agreement for AvidiMab | 04-Sep-19 07:01 |
| Notice of AGM | 20-Aug-19 14:24 |
| Final Results for the year ended 30 April 2019 | 20-Aug-19 07:03 |
| Update on the SCIB1 Phase 2 clinical trial | 19-Aug-19 07:02 |